Table 3.
Immunophenotyping of peripheral blood cell subsets in patients with AD undergoing AHSCT.
| CELL SUBSET | PHENOTYPE |
|---|---|
| Minimum panel for immune reconstitution analyses | |
| Total CD3, CD4, or CD8 T cells | CD3+CD4+CD8−; CD3+CD4−CD8+ |
| Recent thymic emigrants | CD3+CD4+CD31+CD45RA+CD45RO− |
| Naive T cellsa, b | CD3+CD4+(CD8+)CD45RA+CD45RO−CCR7+CD62L+ |
| Central memory T cellsa, b | CD3+CD4+(CD8+)CD45RA−CD45RO+CCR7+CD62L+ |
| Effector memory T cellsa, b | CD3+CD4+(CD8+)CD45RA−CD45RO+CCR7−CD62L− |
| Effector T cellsa, b | CD3+CD4+(CD8+)CD45RA+CD45RO−CCR7−CD62L− |
| Exausted T cellsc | CD3+CD4+CD8−PD-1+; CD3+CD4−CD8+PD-1+ |
| Naive B cells | CD19+CD27−IgD+ |
| Switched memory B cells | CD19+CD27+IgD− |
| Non-Switched memory B cells | CD19+CD27+IgD+ |
| Plasma cells | CD19+CD27highIgD−CD38high |
| Regulatory B cells (Breg) | CD19+CD24highCD38high or CD19+CD24highCD38highIgMhighIgMhighCD5+CD10+CD20+CD27−CD1dhigh |
| Regulatory T cells (nTreg) | CD4+CD25highCD127−Foxp3+ |
| Suppressor T cells (CD8) | CD8+CD28−CD57+PD1+ |
| NK cells (cytotoxic) | CD3− CD56dimCD16+ |
| NK cells (cytotoxic) | CD3− CD56brightCD16+/− |
| iNKT cells | CD19−CD3+Vα24−Jα18 TCR+ |
| Stem cell-like memory T cells (TSCM) | CD3−CD4+(CD8+)CD45RO−CD45RA+CCR7+CD27+CD28+CD95+CD122+ |
| Other cell subsets for immune reconstitution analyses | |
| Follicular T helper (Tfh) | CD3+CD4+CXCR5+PD-1+Bcl-6+FoxP3− or CD3+CD4+CXCR5+PD-1+ICOS+ |
| Th1 cells | CD3+CD4+CXCR3+CCR6−Tbet+ or CD3+CD4+CXCR5−CXCR3+ |
| Th2 cells | CD3+CD4+CCR4+CCR6−GATA3+ or CD3+CD4+CXCR5−CCR4+CCR6− |
| Th17 cells | CD3+CD4+CCR6+CCR4+RORγt+ or CD3+CD4+CXCR5−CCR4+CCR6+CCR10− |
| Th22 cells | CD3+CD4+CCR10+CCR4+AHR+ or CD3+CD4+CXCR5−CCR4+CCR6+CCR10+ |
| Monocytes (classic) | CD14+CD16− |
| Monocytes (inflammatory) | CD14+CD16+CD64high CD32low |
| Monocytes (patrolling) | CD14lowCD16+ |
| Myeloid-derived suppressor cells (MDSCs) granulocyticd | Lin-CD14−HLADR−CD33+CD11b+ |
| Myeloid-derived suppressor cells (MDSCs) monocyticd | Lin-CD14+HLADR−CD11b+ |
| Plasmocytoid dendritic cellsd | Lin−CD14−CD123+CD11c− |
| Conventional dendritic cellsd | Lin−CD14−CD123−CD11c+ |
| Upon in vitro t or b cell activation | |
| Signaling Pathways (Erk, p38MAPK)e | CD3+CD4+CD8−ERK; CD3+CD4+CD8−p38MAPK |
| Cytokine-producing CD4+ ou CD8+ T cells | CD3+CD4+(CD8+) IL2−/+IL4−/+IL17−/+TNFα−/+IL10−/+IFNγ−/+ |
| IL-10-producing Breg cells | CD19+CD24highCD38highIL10+ |
| IL-10-producing Treg cells | CD4+CD25highCD127−Foxp3+IL10+ |
CD4+(CD8+) = CD4+ or CD8+ T cells.
CD45RO and CD62L are not essential to the panel.
Other exhaustion markers (such as TIM-3, LAG-3) or activation markers (CD69, HLA-DR) can be used.